Imatinib Active Not Recruiting Phase 2 Trials for Gastrointestinal Stromal Tumors (GISTs) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00867113Five Year Adjuvant Imatinib Mesylate (GleevecĀ®) in Gastrointestinal Stromal Tumor (GIST)